News from NORD

New Guidelines Published for Diagnosis and Management of Cystathionine Beta-Synthase Deficiency

Publish date: December 5, 2016

 

New guidelines for the diagnosis and management of cystathionine beta-synthase deficiency have been published in the Journal of Inherited Metabolic Disease . The HCU Network Australia recently hosted an online webinar featuring Andrew Morris MD, the primary author of the new guidelines.

Recommended Reading

Myeloablative HSCT bests IV CYC for systemic scleroderma
MDedge Internal Medicine
Prenatal exposure to hydroxychloroquine cuts risk of neonatal cutaneous lupus
MDedge Internal Medicine
NORD Encourages Observing Rare Disease Day in Hospitals and Academic Centers
MDedge Internal Medicine
January 13 Is Deadline for NORD Rare Impact Award Nominations
MDedge Internal Medicine
Running Marathons to Advance Rare Disease Awareness and Diagnosis
MDedge Internal Medicine
Major Three-Year Study of Undiagnosed Diseases Announced
MDedge Internal Medicine
The Journey to an FTD Diagnosis Webinar Now Available
MDedge Internal Medicine
Presentation Chronicles Pathway to Erdheim-Chester Diagnosis
MDedge Internal Medicine
Patients Are Being Recruited for LPL-Deficiency Study
MDedge Internal Medicine
Speaking of NEC Podcast Series Now Has Companion Brochure
MDedge Internal Medicine